Titan Medical reports $4M in research, development expenses in Q3 2017: 4 notes

Titan Medical reported its 2017 third quarter financial results, with research and development expenses totaling over $4 million.

Advertisement

Here are four notes:

 

1. Third quarter net and comprehensive loss, including adjustment for warrant liability, was $13.9 million, compared to $1.6 million in the third quarter of 2016.

 

2. Cash, cash equivalents and deposits with suppliers as of Sept. 30, were just over $7.2 million compared with $6.3 million as of Dec. 31, 2016.

 

3. During the third quarter Titan Medical installed its first two installations of the SPORT Surgical System at Columbia University Medical Center in New York City and Celebration-based Florida Hospital Nicholson Center.

 

4. Titan Medical also completed a $2.6 million private placement, during the third quarter, and received $7.1 million in proceeds from the exercise of share purchase and broker warrants.

 

More articles on devices and implants:
Xtant Medical postpones Q3 2017 financial results release: 3 insights
3 NASS presentations highlight evidence for lumbar total disc replacement
Safe Orthopaedics names François-Henri Reynaud new chief financial, administrative officer — 3 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.